Fibrinolysis by tissue plasminogen activator in a child with pulmonary embolism
Authors:
- Mary Ella M. PierpontMPMary Ella M. Pierpont
- Marie E. SteinerMSMarie E. Steiner
- Peter S. HessleinPHPeter S. Hesslein
- Cark M. SmithCSCark M. Smith
- 1 May 1990
- journal article
- case report
- Published by Elsevier in The Journal of Pediatrics
- Vol. 116 (5) , 801-804
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Safety and efficacy of tissue-type plasminogen activator produced by recombinant DNA technologyJACC, 1987
- Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activatorJACC, 1987
- Urokinase therapy for a catheter‐related right atrial thrombus and pulmonary embolism in a 2‐month‐old infantPediatric Pulmonology, 1986
- Fibrinolytic therapy for femoral arterial thrombosis after cardiac catheterization in infants and childrenThe American Journal of Cardiology, 1986
- A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.Circulation, 1985
- Low-dose fibrinolytic therapy in infantsThe Journal of Pediatrics, 1985
- Thrombolysis with Human Extrinsic (Tissue-Type) Plasminogen Activator in Rabbits with Experimental Jugular Vein Thrombosis. EFFECT OF MOLECULAR FORM AND DOSE OF ACTIVATOR, AGE OF THE THROMBUS, AND ROUTE OF ADMINISTRATIONJournal of Clinical Investigation, 1983
- Urokinase therapy for a catheter-related right atrial thrombusThe Journal of Pediatrics, 1982
- Pulmonary embolism in childrenJournal of Pediatric Surgery, 1981
- The Pathology of Hypertensive Pulmonary Vascular DiseaseCirculation, 1958